Browsing Tag
Kyowa Kirin
5 posts
Amgen and Kyowa Kirin report Phase 3 rocatinlimab results highlighting long-term safety and durable response in atopic dermatitis
Amgen and Kyowa Kirin report Phase 3 rocatinlimab results showing long-term safety and durable efficacy in atopic dermatitis. Find out what comes next.
Amgen and Kyowa Kirin see breakthrough in rocatinlimab Phase 3 Trial, eyes on FDA path
Amgen and Kyowa Kirin have reported positive top-line results from the Rocatinlimab Phase 3 IGNITE trial, part of…
Why Kura Oncology shares tumbled after securing a $1.2bn cancer-drug partnership
Kura Oncology, Inc., a clinical-stage biopharmaceutical innovator, and Japan-based pharmaceutical leader Kyowa Kirin Co., Ltd., have entered into…
Kyowa Kirin secures extended EC approval for CRYSVITA in X-linked hypophosphataemia treatment
Kyowa Kirin has recently received expanded approval from the European Commission (EC) for its recombinant monoclonal antibody treatment,…
Ultragenyx Pharmaceutical, Kyowa Kirin bag Crysvita FDA approval for TIO
Crysvita FDA approval for TIO : Ultragenyx Pharmaceutical and Kyowa Kirin have secured approval for their recombinant fully…